Literature DB >> 25315108

Considerations in the treatment of tension-type headache in the elderly.

Stephanie Wrobel Goldberg1, Stephen Silberstein, Brian M Grosberg.   

Abstract

Tension-type headache (TTH) is the most prevalent headache type in all age groups worldwide, including patients with advanced age. Because of its high prevalence and possible association with medical and psychiatric co-morbidities, TTH has a major socioeconomic impact. The lifetime prevalence of TTH ranges between 30 and 78 %, and the 1-year prevalence in individuals over the age of 55 years is 35.8 % (27.8 % in men, 42.4 % in women). Since the prevalence of secondary headache disorders increases in the elderly, the initial evaluation of this group of patients with a new-onset headache or a change in a pre-existing headache pattern should be directed towards their exclusion. This article reviews the diagnostic and treatment dilemmas encountered in elderly patients with tension-type headaches, highlighting both pharmacological and non-pharmacological interventions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25315108     DOI: 10.1007/s40266-014-0220-2

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  78 in total

1.  Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  S D Silberstein
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

2.  Fluoxetine for migraine prophylaxis: a double-blind trial.

Authors:  C C d'Amato; V Pizza; T Marmolo; E Giordano; V Alfano; A Nasta
Journal:  Headache       Date:  1999 Nov-Dec       Impact factor: 5.887

3.  Meta-analysis of biofeedback for tension-type headache: efficacy, specificity, and treatment moderators.

Authors:  Yvonne Nestoriuc; Winfried Rief; Alexandra Martin
Journal:  J Consult Clin Psychol       Date:  2008-06

4.  Use of nonsteroidal anti-inflammatory drugs in the older adult.

Authors:  Terri O Fowler; Catherine O Durham; Jonathan Planton; Barbara J Edlund
Journal:  J Am Assoc Nurse Pract       Date:  2014-06-23       Impact factor: 1.165

5.  An open-label dose-titration study of the efficacy and tolerability of tizanidine hydrochloride tablets in the prophylaxis of chronic daily headache.

Authors:  J R Saper; P K Winner; A E Lake
Journal:  Headache       Date:  2001-04       Impact factor: 5.887

6.  2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study.

Authors:  R B Lipton; W F Stewart; R Cady; C Hall; S O'Quinn; T Kuhn; D Gutterman
Journal:  Headache       Date:  2000 Nov-Dec       Impact factor: 5.887

Review 7.  Central sensitization in tension-type headache--possible pathophysiological mechanisms.

Authors:  L Bendtsen
Journal:  Cephalalgia       Date:  2000-06       Impact factor: 6.292

8.  Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.

Authors:  R Norman Harden; Jerod Cottrill; Christine M Gagnon; Todd A Smitherman; Stephan R Weinland; Beverley Tann; Petra Joseph; Thomas S Lee; Timothy T Houle
Journal:  Headache       Date:  2008-10-24       Impact factor: 5.887

9.  Biofeedback treatment for headache disorders: a comprehensive efficacy review.

Authors:  Yvonne Nestoriuc; Alexandra Martin; Winfried Rief; Frank Andrasik
Journal:  Appl Psychophysiol Biofeedback       Date:  2008-08-26

Review 10.  Important drug-drug interactions in the elderly.

Authors:  R M Seymour; P A Routledge
Journal:  Drugs Aging       Date:  1998-06       Impact factor: 4.271

View more
  1 in total

Review 1.  Pharmacogenetics in Primary Headache Disorders.

Authors:  Irina I Belyaeva; Anna G Subbotina; Ivan I Eremenko; Vadim V Tarasov; Vladimir N Chubarev; Helgi B Schiöth; Jessica Mwinyi
Journal:  Front Pharmacol       Date:  2022-02-10       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.